Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Recherche En Soins Infirmiers|May 23, 2006
[Clinical management. A always current tool]Pierre Désaulniers, Jean F Letendre
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
A phase II study of recombinant tumor necrosis factor in renal cell carcinoma: a study of the National Cancer Institute of Canada Clinical Trials GroupJ Skillings, R Wierzbicki, E Eisenhauer, et al.
Blood|October 15, 1990
Coordinate secretion of interleukin-1 beta and granulocyte-macrophage colony-stimulating factor by the blast cells of acute myeloblastic leukemia: role of interleukin-1 as an endogenous inducerJ C Rodriguez-Cimadevilla, V Beauchemin, L Villeneuve, et al.
Investigational New Drugs|January 1, 1994
Phase II study of elsamitrucin in non-small cell lung cancerG Goss, F Letendre, D Stewart, et al.
The Journal of Experimental Medicine|August 1, 1988
Interleukin 1 enhances growth factor-dependent proliferation of the clonogenic cells in acute myeloblastic leukemia and of normal human primitive hemopoietic precursorsT Hoang, A Haman, O Goncalves, et al.
International Journal of Clinical Pharmacology and Biopharmacy|February 1, 1979
Lidocaine plasma concentrations during and after endoscopic proceduresJ le Lorier, P Larochelle, P Bolduc, et al.
Oncology|January 1, 1991
Acute and delayed emesis after cisplatin-based regimen: description and preventionC Louvet, A Lorange, F Letendre, et al.
Journal of Medical Genetics|December 1, 1995
A large multisite cancer family is linked to BRCA2P Tonin, P Ghadirian, C Phelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials GroupM E Trudeau, E A Eisenhauer, B P Higgins, et al.
Bone Marrow Transplantation|January 10, 2002
Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effectR Le Blanc, S Montminy-Métivier, R Bélanger, et al.
Pageof 1